autologous hematopoietic stem cells transduced with Factor VIII (Discovery genomics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous hematopoietic stem cells transduced with Factor VIII (Discovery genomics)
Drug Alias Namehematopoietic Factor VIII gene therapy (DGI)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiscovery Genomics IncUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A